Intervention1: Ferric Carboxymaltose Injection 750 mg iron/15 mL

2 trials

Sponsors

Dr Sanjeev Hegde, Orbicular Pharmaceutical Technologies Pvt Ltd

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Unknown Phase

Pharmacokinetic Study of Ferric Carboxymaltose injection in Iron deficiency anemia patients.

Active, not recruitingCTRI/2021/07/034733

Dr Sanjeev HegdeHealth Condition 1: D509- Iron deficiency anemia, unspecified

Target: 150Updated: 2022-10-17

PK Study of Ferric Carboxymaltose injection in Iron deficiency anemia patients.

Active, not recruitingCTRI/2023/07/054917

Orbicular Pharmaceutical Technologies Pvt LtdHealth Condition 1: D509- Iron deficiency anemia, unspecified

Target: 150Updated: 2024-10-14